论文部分内容阅读
博安霉素(Boanmycin Hydrochloride)为中国医学科学院医学生物技术研究所与河北制药厂共同研制的抗肿瘤新药。实验研究表明其抗瘤谱广、毒性低。我院于1994年6月～1995年2月对博安霉素进行Ⅱ期临床研究,共治疗恶性肿瘤18例,现将结
Boanmycin Hydrochloride is a new antitumor drug jointly developed by the Institute of Medical Biotechnology of the Chinese Academy of Medical Sciences and the Hebei Pharmaceutical Factory. Experimental studies have shown that its anti-tumor spectrum is broad and its toxicity is low. In our hospital from June 1994 to February 1995, a phase II clinical study of boanmycin was conducted. A total of 18 cases of malignant tumors were treated.